Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 6Unknown 3

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Sarcoma 5Wilms Tumor 3Kidney Neoplasms 3Neuroectodermal Tumors, Primitive, Peripheral 2Gestational Trophoblastic Disease 2Neoplasms 1Malignant mesenchymal tumor 1

Interventions

Vincristine 3Radiotherapy 3Dactinomycin 3Cyclophosphamide 3Etoposide 2Doxorubicin 2Carboplatin 2Surveys and Questionnaires 1Ritonavir 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Neoadjuvant Therapy 1Melphalan 1Indinavir 1Hematologic Tests 1Genetic Testing 1Genes, p53 1Gelclair 1Flow Cytometry 1Drug Therapy 1Decitabine 1Chemotherapy, Adjuvant 1Blood Specimen Collection 1Biological Factors 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Wilms Tumor × Dactinomycin × Clear all
NCT00003804 2014-06-24

Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor

National Cancer Institute (NCI)

Phase 3 Unknown
350 enrolled
Genitourinary

Kidney Neoplasms, Wilms Tumor

NCT00047138 2014-06-24

Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor

National Cancer Institute (NCI)

Phase 3 Unknown
350 enrolled
Genitourinary

Kidney Neoplasms, Wilms Tumor

NCT00025103 2013-08-02

Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney

National Cancer Institute (NCI)

Phase 2 Unknown
75 enrolled
Genitourinary

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡